Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

CliniSenz

Financiado

Cerrado

CliniSenz TM A Cost effective Biosensor for Automatic Continuous Blood Glucos...

CliniSenz TM A Cost effective Biosensor for Automatic Continuous Blood Glucose Monitoring We are a Swedish medical devices manufacture, Senzime AB, who have been driven by the need to take advantage of an existing core technology to embark on a new strategy to grow based on our vision of becoming the leading provider o... ver más

30/11/2015

Senzime AB

71K€

Presupuesto del proyecto: 71K€

Líder del proyecto

SENZIME AB No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2015-11-30

PHC-12-2015-1: Clinical research for the validatio...

I+D

Cerrada hace 9 años

0% 70% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

Senzime AB

50.00K€ | Lider

Proyectos interesantes

WASP

Medical Technol...

Data Science

150K€ Cerrado

EUIN2013-51025

Medical Technol...

Data Science

18K€ Cerrado

PTQ2023-013156

Medical Technol...

Data Science

109K€ Cerrado

PTQ2021-012005

Medical Technol...

Data Science

100K€ Cerrado

GLUMON

Medical Technol...

Data Science

2M€ Cerrado

GlucoSet

Medical Technol...

Data Science

6M€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 5 meses Fecha Inicio: 2015-05-31
Fecha Fin: 2015-11-30

Líder del proyecto

SENZIME AB No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 71K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto We are a Swedish medical devices manufacture, Senzime AB, who have been driven by the need to take advantage of an existing core technology to embark on a new strategy to grow based on our vision of becoming the leading provider of analyte evaluation systems, with a turnover of €30.5m by 2020. To realise this vison we will add a new product line to our portfolio by exploiting an existing biosensor technology that we have developed, as well as the experience and contacts gained on a parallel project, which is currently yielding high growth. We have identified within our target market the need of health care providers to be able to track blood glucose levels continuously which is not currently being met in a cost effective and practical way by existing products. To overcome these deficiencies we have developed the CliniSenzTM system with innovative features and functionality which in turn creates performance advantages of being more sensitive, specific and continuous. These performance advantages, in turn generate real commercial customer benefits, such as reduced mortality rates, faster recovery rates and the freeing up of healthcare professionals. Since 2004 Senzime has been working to develop prototypes and has conducted clinical trials which has allowed us to have achieved TRL 6. We now seek to create a feasibility report and detailed business/investment plan which will enable us to secure funding to reach TRL 8 and launch the product. This new product will be key to realising our growth strategy relating to achieving growth in sales. Based on projected demand from ICUs across the UK and US, we have forecasted sales worth €30.5 million to us by 2020.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores